News | October 04, 2024
Lilly invests US$ 4.5 billion to create advanced research and manufacturing site
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients
Subscribe To Our Newsletter & Stay Updated
